Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen Highlights Phase 2 Results Of Vectibix Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer
Yahoo/PR NewsWire
Sat, 05/31/14 - 10:07 am
Tags:
Amgen, bevacizumab, colon cancer, colorectal cancer, Vectibix
Amgen gets expanded approval for colon cancer drug
Yahoo/AP
Sat, 05/24/14 - 09:49 am
Tags:
Amgen, colon cancer, Vectibix
3 Biotech Dividend Darlings for Your Portfolio
Motley Fool
Sat, 05/17/14 - 09:56 am
Tags:
Amgen, PDL Biopharma, Teva Pharmaceuticals
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
Seeking Alpha
Fri, 05/16/14 - 08:20 am
Tags:
Amgen, Biocryst, GSK, Corcept Therapeutics, Merck KGaA, Ligand Pharmaceuticals, MannKind, Pfizer, Shire, Receptos, Opexa
Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
The Fly on the Wall
Tue, 05/13/14 - 10:21 pm
Tags:
Amgen, evolocumab
What's Hurting Biotechnology Stocks?
Seeking Alpha
Tue, 05/13/14 - 11:37 am
Tags:
biotech, Gilead Sciences, InterMune, MannKind, Amgen, Celgene, Biogen Idec
This Week in Biotech: Chelsea Therapeutics Finds a Buyer While Corcept Implodes
Motley Fool
Sat, 05/10/14 - 12:45 pm
Tags:
Chelsea Therapeutics, Corcept Therapeutics, Lundbeck, Theravance, GSK, AstraZeneca, Amgen
Amgen, AstraZeneca reports brodalumab study met primary, secondary endpoints
The Fly on the Wall
Sat, 05/10/14 - 10:48 am
Tags:
Amgen, AstraZeneca, brodalumab
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala
Seeking Alpha
Wed, 04/30/14 - 12:50 pm
Tags:
melanoma, Bristol-Myers Squibb, Roche, Merck, Amgen
Amgen, AbbVie Seen as Possible AstraZeneca White Knights
Bloomberg
Mon, 04/28/14 - 10:14 am
Tags:
Amgen, Pfizer, AstraZeneca, AbbVie, M&A
Should Amgen Break Itself Up?
Forbes
Wed, 04/23/14 - 10:56 am
Tags:
Amgen
Amgen Falls as Earnings, Revenue Disappoint
Barron's
Tue, 04/22/14 - 04:55 pm
Tags:
Amgen, earnings
Earnings Preview: Amgen's timeline for Evolocumab will be in focus
The Fly on the Wall
Tue, 04/22/14 - 03:33 pm
Tags:
earnings, Amgen, evolocumab
Pfizer, AstraZeneca Are Ripe for Pharma Deal Alone or Together
Yahoo/Bloomberg
Tue, 04/22/14 - 10:07 am
Tags:
Pfizer, AstraZeneca, M&A, Bristol-Myers Squibb, Shire, Amgen, AbbVie
What to Watch for in Biotech Earnings This Week
Motley Fool
Tue, 04/22/14 - 09:33 am
Tags:
biotech, earnings, Gilead Sciences, Celgene, Amgen, BiogenIdec
Today's Market: Other Potential Buyout Targets For Pfizer
Seeking Alpha
Mon, 04/21/14 - 11:25 am
Tags:
M&A, Pfizer, AstraZeneca, Celgene, Biogen Idec, Amgen
FDA Grants Fast Track Status To Amgen Heart Failure Drug
Forbes
Fri, 04/18/14 - 08:51 am
Tags:
FDA, Amgen, fast track, ivabradine, heart failure
Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Motley Fool
Thu, 04/17/14 - 11:19 am
Tags:
Amgen, Biogen Idec, earnings
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
Tags:
M&A, Amgen, ONYX Pharmaceuticals, Bausch & Lomb, Valeant Pharmaceuticals, Elan, Perrigo, Actavis, Warner Chilcott, Bristol-Myers Squibb, AstraZeneca, Pearl Therapeutics, Agila, Mylan, Salix, Santarus, Bayer, Algeta, Shire, ViroPharma
[video]Amgen's Conundrum
Motley Fool
Mon, 04/14/14 - 06:18 pm
Tags:
Amgen, Talimogene Laherparepvec

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.